Priothera

Priothera

Priothera

Priothera, a Dublin, Ireland-based clinical stage company developing orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.
Raised
$35.3M
Follow us
Latest funding
Team Size
1–10
Employees
Location
Headquarters
€30,000,000 Venture capital (Series A)
FinSMEs

Priothera Raises €30M in Series A Financing

SiliconRepublic

Dublin’s Priothera raises €30m to develop leukaemia treatment